Thus, the above results further indicated that LINC01132/NRF1/DPP4 axis is involved in the immunosuppression of HCC (Fig. 6F) and suggested that knockdown LINC01132 could improve the efficacy of PDL1 blockage immunotherapy. This evidence concerns the gene CD274 and hepatocellular carcinoma.